Delivery Order SPE2DB22D2006-SPE2DB25FW3CW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,698.09 by the Defense Logistics Agency on July 31, 2025, for the supply of Eliquis 5 mg tablets (60-count). The award utilizes a firm fixed-price contract structure with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $17,176.10 delivery order from the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, competitively awarded contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,157.96 by the Defense Logistics Agency (DLA) on July 28, 2025, with an ultimate completion date of July 29, 2025. The award is for the supply of Eliquis 5 mg tablets in a 60-count quantity, representing a firm fixed price, competitively awarded delivery order with no set-aside designation. This contract award is executed as a child order under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,156.88 by the Defense Logistics Agency Medical Supply Chain on July 25, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on July 24, 2025, for 60 tablets of Eliquis 2.5 mg with a ceiling value of $1,989.38. This non-competitive delivery order is set to be completed by July 25, 2025, and represents a pharmaceutical supply requisition under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract award supports the Defense...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,382.14. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract has a ceiling value of $6,349.14 and carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Eliquis 5 mg, valued at $5,817.26. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $10,330.48 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561966144 units of the Eliquis 5 mg tablet. Performance will take place in Conshohocken, Pennsylvania over a period spanning August 28 through 29, 2023. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract, which establishes...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3CWDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order fulfills federal medical procurement needs within the Defense Logistics Agency's medical supply chain, supporting the Defense Health Agency and other government healthcare systems. Eliquis is an anticoagulant medication utilized in military and veteran healthcare systems for thrombotic disease prevention. As the child contract under the SPE2DX prime IDC, this award demonstrates AmerisourceBergen's continued capacity to meet federal pharmaceutical requirements through the DLA's Pharmaceutical Prime Vendor program, which is transitioning to Generation V contracts with the potential for multiple regional awards among multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.2k | 8/5/25 |